Longeveron Inc. LGVN
Set alert
1.67 USD -0.08 -4.57%
At close · Oct 30
1.67 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
1.58 Day range 1.80
1.39 52-week range 11.60
- YTD
- -67.00%
- 1 year
- -80.05%
- Open
- 1.78
- Prev close
- 1.75
- Mkt cap
- 5.32M
- Vol
- 80.81K
- Avg vol
- 106.45K
- EPS
- -9.90
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.58
- High
- 1.80
- Forward P/E
- -1.16
- Beta
- 0.35
- Short ratio
- 2.03
- Inst. own
- 3.34%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2024
- 50-d avg
- 2.01
- 200-d avg
- 2.26
- 1y target
- 8.88
2Y chart
Events in this range
- Nov 4, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Nov 12, 2024Earnings: -0.34; estimate -0.53; surprise 35.85%
- Nov 25, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Dec 5, 2024Rating: Roth MKM · — → Buy
- Aug 27, 2026Split: 1 for 10
Signals (94)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 7, 2026 | 3 weeks ago |
| RSI: Oversold | Sep 17, 2026 | 1 month ago |
| SMA: Bearish | Sep 15, 2026 | 1 month ago |
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| SMA: Bullish | Sep 11, 2026 | 1 month ago |
| SMA: Bullish | Sep 11, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 26, 2026 | 2 months ago |
| SMA: Bearish | Aug 25, 2026 | 2 months ago |
| SMA: Bearish | Aug 25, 2026 | 2 months ago |
| SMA: Bullish | Aug 14, 2026 | 2 months ago |
| SMA: Bullish | Aug 14, 2026 | 2 months ago |
| SMA: Bearish | Aug 13, 2026 | 2 months ago |
| SMA: Bearish | Aug 13, 2026 | 2 months ago |
| SMA: Bullish | Aug 12, 2026 | 2 months ago |
| SMA: Bullish | Aug 12, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 24, 2026 | 3 months ago |
| MACD: Sell Signal | Jun 26, 2026 | 4 months ago |
| SMA: Bearish | Jun 24, 2026 | 4 months ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| SMA: Bearish | Jun 5, 2026 | 4 months ago |
| MACD: Buy Signal | May 26, 2026 | 5 months ago |
| SMA: Bullish | May 22, 2026 | 5 months ago |
| RSI: Oversold | May 14, 2026 | 5 months ago |
| SMA: Bearish | May 12, 2026 | 5 months ago |
| RSI: Oversold | May 12, 2026 | 5 months ago |
| SMA: Bearish | Apr 29, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 13, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 31, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 30, 2026 | 7 months ago |
| RSI: Overbought | Mar 18, 2026 | 7 months ago |
| SMA: Bullish | Mar 13, 2026 | 7 months ago |
| RSI: Overbought | Mar 13, 2026 | 7 months ago |
| SMA: Bearish | Mar 11, 2026 | 7 months ago |
| SMA: Bullish | Mar 10, 2026 | 7 months ago |
| SMA: Bullish | Mar 10, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 10, 2026 | 7 months ago |
| RSI: Overbought | Mar 10, 2026 | 7 months ago |
| SMA: Bearish | Mar 4, 2026 | 8 months ago |
| MACD: Sell Signal | Mar 4, 2026 | 8 months ago |
| SMA: Bullish | Mar 3, 2026 | 8 months ago |
| SMA: Bearish | Feb 27, 2026 | 8 months ago |
| SMA: Bullish | Feb 26, 2026 | 8 months ago |
| SMA: Bearish | Feb 25, 2026 | 8 months ago |
| SMA: Bullish | Feb 20, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 17, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 4, 2026 | 8 months ago |
| SMA: Bearish | Jan 29, 2026 | 9 months ago |
| SMA: Bullish | Jan 28, 2026 | 9 months ago |
| SMA: Bearish | Jan 27, 2026 | 9 months ago |
| SMA: Bullish | Jan 26, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 22, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 21, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 2, 2026 | 10 months ago |
| MACD: Sell Signal | Dec 18, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 17, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 16, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 1, 2025 | 11 months ago |
| RSI: Oversold | Nov 25, 2025 | 11 months ago |
| RSI: Oversold | Nov 17, 2025 | 11 months ago |
| SMA: Bearish | Nov 4, 2025 | 12 months ago |
| MACD: Sell Signal | Nov 4, 2025 | 12 months ago |
| SMA: Bullish | Oct 20, 2025 | 1 year ago |
| SMA: Bearish | Oct 17, 2025 | 1 year ago |
| SMA: Bullish | Oct 15, 2025 | 1 year ago |
| SMA: Bearish | Oct 10, 2025 | 1 year ago |
| SMA: Bullish | Oct 8, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 27, 2025 | 1 year ago |
| RSI: Oversold | Aug 8, 2025 | 1 year ago |
| SMA: Bearish | Aug 7, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 30, 2025 | 1 year ago |
| SMA: Bullish | Jul 8, 2025 | 1 year ago |
| RSI: Overbought | Jul 8, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 25, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 23, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 10, 2025 | 1 year ago |
| MACD: Sell Signal | May 6, 2025 | 1 year ago |
| SMA: Bearish | May 5, 2025 | 1 year ago |
| SMA: Bullish | Apr 22, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 21, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 31, 2025 | 1 year ago |
| SMA: Bearish | Mar 28, 2025 | 1 year ago |
| SMA: Bullish | Mar 12, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 10, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 3, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 12, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 22, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 21, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 17, 2025 | 1 year ago |
| MACD: Buy Signal | Dec 26, 2024 | 1 year ago |
| RSI: Oversold | Dec 19, 2024 | 1 year ago |
Key statistics
- Market cap
- 26.26M
- Enterprise value
- 22.40M
- Trailing P/E
- 0.00
- Forward P/E
- -1.16
- PEG ratio
- 0.00
- Price / sales
- 21.37
- Price / book
- 0.66
- EPS (TTM)
- -5.62
- Beta
- 0.35
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 1.23M
- Revenue growth
- 115.70%
- Free cash flow
- -10.03M
- Total cash
- 12.38M
- Total debt
- 1.75M
- Return on equity
- -142.16%
- Shares outstanding
- 13.35M
- Short % of float
- 10.24%
- 50-day average
- 2.01
- 200-day average
- 2.26
Analyst view
Consensus: none
Price target (mean) 8.88 +431.4% upside
Now 1.67
- Target (low)
- 6.00
- Target (mean)
- 8.88
- Target (high)
- 10.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy3
- Buy0
- Hold0
- Sell0
- Strong sell0
Next earnings
Aug 14, 2024
Expected Aug 14, 2024. Consensus EPS estimate 0.00.
Financials — quick view
LGVN Revenue — quarterly 287.00K
LGVN Net income — quarterly -6.07M
LGVN EPS — quarterly -1.90
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2024 | Sep 1, 2024 | -0.53 | -0.34 | +0.19 | +35.85% |
| Aug 14, 2024 | Jun 1, 2024 | -1.03 | -1.83 | -0.80 | -77.67% |
| Aug 14, 2024 | Jun 1, 2024 | -1.03 | — | — | — |
| May 14, 2024 | Mar 1, 2024 | -2.01 | -1.61 | +0.40 | +19.90% |
| May 14, 2024 | Mar 1, 2024 | -2.01 | — | — | — |
| Feb 27, 2024 | Dec 1, 2023 | -2.10 | -2.50 | -0.40 | -19.05% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 5, 2024 | Roth MKM | init | — | Buy |
| Nov 25, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Nov 4, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Sep 4, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Aug 27, 2024 | Maxim Group | main | Buy | Buy |
| Aug 15, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
About Longeveron Inc.
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors. It is conducting Phase 1, Phase 1/2, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer's disease, and hypoplastic left heart syndrome. Longeveron Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- longeveron.com
News
- Longeveron Announces Engagement of Lucid Capital Markets
- Longeveron Announces Its ELPIS II Study Of Laromestrocel Failed To Meet Primary Efficacy Endpoint Of Change From Baseline In Right Ventricular Ejection Fraction To Treat Infants With Hypoplastic Left Heart Syndrome
- Longeveron Announces Updated Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS)
- 12 Health Care Stocks Moving In Thursday's After-Market Session
- Longeveron to Participate in Three Longevity/Aging Investment Conferences
- 12 Health Care Stocks Moving In Friday's Intraday Session
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Why Generac Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket
- Longeveron (LGVN) Shares Slide 59% After Hours: Here's Why
Your note
Sign in to keep a note on LGVN — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| AGAFONOVA NATALIYA | Officer | Stock Award(Grant) | Aug 14, 2024 | 163,130 |
| BALUCH KHOSO | Director | Sale | Dec 1, 2024 | 23,750 |
| HARE JOSHUA M | Officer, Director and Beneficial Owner | Stock Award(Grant) | Aug 14, 2024 | 727,046 |
| HARE NEIL E | Director | Stock Award(Grant) | Aug 14, 2024 | 30,246 |
| HASHAD MOHAMED WA'EL AHMED | Chief Executive Officer | Stock Award(Grant) | Aug 14, 2024 | 90,368 |
| KENDER RICHARD N | Director | Stock Award(Grant) | May 9, 2024 | 16,000 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Geode Capital Management, LLC | 0.97% | 128,947 | 228.24K | Sep 29, 2024 |
| Vanguard Group Inc | 0.34% | 44,984 | 79.62K | Sep 29, 2024 |
| Capital Investment Advisory Services, LLC | 0.20% | 26,525 | 46.95K | Sep 29, 2024 |
| State Street Corporation | 0.11% | 15,180 | 26.87K | Sep 29, 2024 |
| Creative Planning | 0.08% | 11,200 | 19.82K | Sep 29, 2024 |
| Blackrock Inc. | 0.08% | 10,016 | 17.73K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.54% | 72,197 | 127.79K | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.34% | 44,984 | 79.62K | Sep 29, 2024 |
| Fidelity Total Market Index Fund | 0.18% | 24,137 | 42.72K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.13% | 17,087 | 30.24K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.03% | 3,572 | 6.32K | Oct 30, 2024 |